Editorial Board
Yi Zhang
Biotherapy Center & Department of Oncology, The First Affiliated Hospital of Zhengzhou University · China
Editorial leadership for Journal of Evolving Stem Cell Research ISSN 2574-4372
Research interests
- My Laboratory Investigates The Key Cellular Components Such As Effector T Cells
- Regulatory Immune Cells
- Caner Stem Cells In Tumor Microenvironment
- Their Clinical Relevance
- Especially In Lung Cancer
- Esophageal Cancer. We Concentrate On The Aberrant Expression Of Cancer-Testis (Ct) Antigens
- The Corresponding Antigen-Specific T Cells In Lung Cancer
- Esophageal Cancer. Furthermore
- We Are Dedicated To Develop Tcr Or Car Gene-Modified T Cells
- Against Tumor Antigens For Potential Antigen-Specific T Cell Therapy
Biography
- Dr. Yi Zhang obtained his PhD degree at University Catholique de Louvain in Belgium and did his postdoctoral training in Drs Thierry Boon and Pierre van der Bruggen’s lab in Ludwig Institute for Cancer Research, Brussels Branch.
- After that, he moved to University of Chicago and worked as Research Assistant Professor in Dr. Hans Schreiber’s lab.
- In 2005, he was recruited as Tenure-track Assistant Professor in Medical University of South Carolina.
- Currently, he is a distinguished Professor and Director in Biotherapy Center & Department of Oncology at the First Affiliated Hospital of Zhengzhou University.
- His laboratory investigates the key cellular components such as effector T cells, regulatory immune cells and caner stem cells in tumor microenvironment and their clinical relevance,especially in lung cancer and esophageal cancer.
- He concentrates on the aberrant expression of cancer-testis (CT) antigens (such as MAGE-A3, MAGE-C2, NY-ESO-1 etc.) and the corresponding antigen-specific T cells in lung cancer and esophageal cancer.
- Furthermore, they are dedicated to develop TCR or CAR gene-modified T cells and against tumor antigens for potential antigen-specific T cell therapy.
- He published 135 papers and more than 60 publications in internationally peer-reviewed journals.
- He published 135 papers and more than 60 publications in internationally peer-reviewed journals.
- He published 135 papers and more than 60 publications in internationally peer-reviewed journals.
Considering JESR for your work?
This journal is guided by Yi Zhang (Biotherapy Center & Department of Oncology, The First Affiliated Hospital of Zhengzhou University) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.